285 related articles for article (PubMed ID: 12825415)
1. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
Hara T; Araake M; Tsuruoka T; Watabe H
Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
[TBL] [Abstract][Full Text] [Related]
2. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
Abe T; Sato Y; Sei M
Jpn J Antibiot; 2003 Dec; 56(6):574-83. PubMed ID: 15007873
[TBL] [Abstract][Full Text] [Related]
3. [In vitro susceptibilities of clinical isolates of Staphylococcus aureus].
Igari J; Shimoji K; Uezu N; Nakasone I; Taira K; Kakazu R
Jpn J Antibiot; 1988 Sep; 41(9):1205-11. PubMed ID: 3241323
[TBL] [Abstract][Full Text] [Related]
4. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
Matsuo K; Uete T
Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
[TBL] [Abstract][Full Text] [Related]
5. [Antimicrobial activity of fosfomycin under various conditions against standard strains, beta-lactam resistant strains, and multidrug efflux system mutants].
Mikuniya T; Hiraishi T; Maebashi K; Ida T; Takata T; Hikida M; Yamada S; Gotoh N; Nishino T
Jpn J Antibiot; 2005 Apr; 58(2):105-22. PubMed ID: 15997654
[TBL] [Abstract][Full Text] [Related]
6. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam in combination against methicillin-susceptible and -resistant Staphylococcus aureus studied using checkerboard MIC method and disc diffusion method with discs containing both drugs].
Matsuo K; Uete T
Jpn J Antibiot; 1993 Mar; 46(3):222-33. PubMed ID: 8510319
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
Matsuo K; Uete T
Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
[TBL] [Abstract][Full Text] [Related]
8. [Studies on phage type, beta-lactamase activity and sensitivity of multiple drug-resistant Staphylococcus aureus isolated from clinical specimens to cefmetazole].
Toyonaga Y; Kurosu Y; Sugita M; Kumagai K; Hori M; Hoshina S; Kurosaka K; Nishiyama H; Shinohara N; Takahashi T; Deguchi K 210 P
Jpn J Antibiot; 1982 Jul; 35(7):1673-85. PubMed ID: 6217356
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
Matsuo K; Uete T
Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
[TBL] [Abstract][Full Text] [Related]
10. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
[TBL] [Abstract][Full Text] [Related]
11. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2003].
Sato Y; Abe T; Koga T; Ito K; Tochikawa Y
Jpn J Antibiot; 2005 Jun; 58(3):303-16. PubMed ID: 16161756
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibility and beta-lactamase-producing strains of methicillin-resistant Staphylococcus aureus].
Akimoto Y; Kaneko K; Fujii A
Nichidai Koko Kagaku; 1989 Sep; 15(3):338-41. PubMed ID: 2489806
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
[TBL] [Abstract][Full Text] [Related]
14. [Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus].
Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Satoh K; Toyonaga Y
Jpn J Antibiot; 1985 Aug; 38(8):2163-70. PubMed ID: 3852898
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.
Matsuda K; Asahi Y; Sanada M; Nakagawa S; Tanaka N; Inoue M
J Antimicrob Chemother; 1991 Jun; 27(6):809-15. PubMed ID: 1938687
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between coagulase typing and antibiotic susceptibility in methicillin resistant Staphylococcus aureus].
Takesue Y; Yokoyama T; Kodama T; Fujimoto M; Sewake H; Murakami Y
Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):5-11. PubMed ID: 2649789
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
[TBL] [Abstract][Full Text] [Related]
18. [In vitro synergistic effects of tazobactam/piperacillin with various antibiotics].
Nishida K; Niidome K; Hashimoto M; Otsuki M; Nishino T
Jpn J Antibiot; 1994 Oct; 47(10):1348-62. PubMed ID: 7807695
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Graninger W; Leitha T; Havel M; Georgopoulos A
Infection; 1984; 12(4):293-5. PubMed ID: 6092279
[TBL] [Abstract][Full Text] [Related]
20. [The taxonomic distribution, characteristic and susceptibility against antimicrobial agents of methicillin-resistant staphylococci isolated from blood].
Kawaguchi E; Minamide W; Mori H; Igimi H
Kansenshogaku Zasshi; 1996 Nov; 70(11):1147-53. PubMed ID: 8986068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
